Ectopic	0	7	O
localization	8	20	O
of	21	23	O
mitochondrial	24	37	B-Gene_or_gene_product
ATP	38	41	I-Gene_or_gene_product
synthase	42	50	I-Gene_or_gene_product
:	50	51	O
a	52	53	O
target	54	60	O
for	61	64	O
anti	65	69	O
-	69	70	O
angiogenesis	70	82	O
intervention	83	95	O
?	95	96	O

A	98	99	O
receptor	100	108	O
for	109	112	O
angiostatin	113	124	B-Gene_or_gene_product
was	125	128	O
identified	129	139	O
on	140	142	O
the	143	146	O
surface	147	154	O
of	155	157	O
endothelial	158	169	B-Cell
cells	170	175	I-Cell
as	176	178	O
F	179	180	B-Gene_or_gene_product
(	180	181	I-Gene_or_gene_product
1	181	182	I-Gene_or_gene_product
)	182	183	I-Gene_or_gene_product
-	183	184	I-Gene_or_gene_product
F	184	185	I-Gene_or_gene_product
(	185	186	I-Gene_or_gene_product
0	186	187	I-Gene_or_gene_product
)	187	188	I-Gene_or_gene_product
ATP	189	192	I-Gene_or_gene_product
synthase	193	201	I-Gene_or_gene_product
(	202	203	O
Moser	203	208	O
et	209	211	O
al	212	214	O
.	214	215	O
,	215	216	O
1999	217	221	O
)	221	222	O
.	222	223	O

Proc	224	228	O
.	228	229	O

Natl	230	234	O
.	234	235	O

Acad	236	240	O
.	240	241	O

Sci	242	245	O
.	245	246	O

U	247	248	O
.	248	249	O
S	249	250	O
.	250	251	O
A	251	252	O
.	252	253	O

96	254	256	O
,	256	257	O
2811	258	262	O
-	262	263	O
2816	263	267	O
.	267	268	O

This	269	273	O
ectopic	274	281	O
ATP	282	285	B-Gene_or_gene_product
synthase	286	294	I-Gene_or_gene_product
catalyzes	295	304	O
ATP	305	308	B-Drug_or_compound
synthesis	309	318	O
and	319	322	O
is	323	325	O
inhibited	326	335	O
by	336	338	O
angiostatin	339	350	B-Gene_or_gene_product
over	351	355	O
a	356	357	O
wide	358	362	O
pH	363	365	O
range	366	371	O
.	371	372	O

Endothelial	373	384	B-Cell
cells	385	390	I-Cell
grown	391	396	O
at	397	399	O
normal	400	406	O
pH	407	409	O
suffer	410	416	O
no	417	419	O
ill	420	423	O
effects	424	431	O
from	432	436	O
this	437	441	O
angiostatin	442	453	B-Gene_or_gene_product
-	453	454	O
mediated	454	462	O
inhibition	463	473	O
of	474	476	O
ATP	477	480	B-Gene_or_gene_product
synthase	481	489	I-Gene_or_gene_product
,	489	490	O
whereas	491	498	O
endothelial	499	510	B-Cell
cells	511	516	I-Cell
grown	517	522	O
at	523	525	O
low	526	529	O
,	529	530	O
tumor	531	536	B-Pathological_formation
-	536	537	O
like	537	541	O
extracellular	542	555	O
pH	556	558	O
cannot	559	565	O
maintain	566	574	O
a	575	576	O
normal	577	583	O
intracellular	584	597	O
pH	598	600	O
and	601	604	O
die	605	608	O
.	608	609	O

Angiostatin	610	621	B-Gene_or_gene_product
inhibits	622	630	O
both	631	635	O
ATP	636	639	B-Drug_or_compound
synthesis	640	649	O
and	650	653	O
ATP	654	657	B-Drug_or_compound
hydrolysis	658	668	O
(	669	670	O
Moser	670	675	O
et	676	678	O
al	679	681	O
.	681	682	O
,	682	683	O
2001	684	688	O
)	688	689	O
and	690	693	O
interferes	694	704	O
with	705	709	O
intracellular	710	723	O
pH	724	726	O
regulation	727	737	O
(	738	739	O
Wahl	739	743	O
and	744	747	O
Grant	748	753	O
,	753	754	O
2002	755	759	O
;	759	760	O
Wahl	761	765	O
et	766	768	O
al	769	771	O
.	771	772	O
,	772	773	O
2002	774	778	O
)	778	779	O
.	779	780	O

Although	781	789	O
angiostatin	790	801	B-Gene_or_gene_product
administered	802	814	O
intravenously	815	828	O
is	829	831	O
cleared	832	839	O
from	840	844	O
the	845	848	O
circulation	849	860	O
in	861	863	O
a	864	865	O
matter	866	872	O
of	873	875	O
minutes	876	883	O
,	883	884	O
angiostatin	885	896	B-Drug_or_compound
-	896	897	I-Drug_or_compound
mimetics	897	905	I-Drug_or_compound
that	906	910	O
are	911	914	O
more	915	919	O
stable	920	926	O
have	927	931	O
potential	932	941	O
for	942	945	O
clinical	946	954	O
application	955	966	O
.	966	967	O

An	968	970	O
angiostatin	971	982	B-Drug_or_compound
-	982	983	I-Drug_or_compound
mimetic	983	990	I-Drug_or_compound
activity	991	999	O
has	1000	1003	O
recently	1004	1012	O
been	1013	1017	O
observed	1018	1026	O
using	1027	1032	O
a	1033	1034	O
polyclonal	1035	1045	O
antibody	1046	1054	O
against	1055	1062	O
the	1063	1066	O
beta	1067	1071	O
catalytic	1072	1081	O
subunit	1082	1089	O
of	1090	1092	O
ATP	1093	1096	B-Gene_or_gene_product
synthase	1097	1105	I-Gene_or_gene_product
.	1105	1106	O

In	1107	1109	O
order	1110	1115	O
to	1116	1118	O
explore	1119	1126	O
the	1127	1130	O
mechanism	1131	1140	O
of	1141	1143	O
action	1144	1150	O
of	1151	1153	O
angiostatin	1154	1165	B-Gene_or_gene_product
and	1166	1169	O
its	1170	1173	O
mimetics	1174	1182	O
,	1182	1183	O
further	1184	1191	O
work	1192	1196	O
needs	1197	1202	O
to	1203	1205	O
be	1206	1208	O
done	1209	1213	O
to	1214	1216	O
evaluate	1217	1225	O
clinical	1226	1234	O
applicability	1235	1248	O
,	1248	1249	O
specificity	1250	1261	O
,	1261	1262	O
and	1263	1266	O
contraindications	1267	1284	O
for	1285	1288	O
this	1289	1293	O
class	1294	1299	O
of	1300	1302	O
therapeutics	1303	1315	O
.	1315	1316	O

